All Type of News
Hanmi Pharm registers ‘Esomezol’
‘Esomezol,’ an acid reflux treatment developed by Hanmi Pharm, was registered at the U.S. Pharmacopeial(USP) for the first time as a Korean pharmaceutical company. Esomezol is the Korea’s first incrementally modified ...
Rapid adoption of AI in developing new drugs ahead of Fourth Industrial Revolution
Ahead of the Fourth Industrial Revolution, Korean and foreign pharmaceutical companies are quickly moving forward to utilize artificial intelligence(AI) into developing new drugs. The trend has been highlighted in maj...
Small distribution companies’ expectations to save expenses meet trend of expanding storages among medium-sized companies
Contract services have been rapidly spread in combination with current pharmaceutical distribution companies’ expansion of their distribution centers and new companies’ expectations to save expenses.
According to the...
Sanofi eliminates a series of existing client distribution companies in Boehringer’s OTC business
It was told as Sanofi acquires the Boehringer Ingelheim’s OTC business, Sanofi stopped having businesses with a number of its existing client pharmaceutical distribution.
Because the distribution companies whose busi...
“It is not allowed to provide indirect rebates using support for foreign symposiums”
The pharmaceutical industry stressed importance of following the fair trade agreement and law by introducing examples of indirect provision of rebates using support for doctors on foreign symposium.
It basically mean...
“We’ll exclude unethical companies in certifying innovative pharmaceutical company”
The Ministry of Health and Welfare(MOHW) will tighten social responsibilities and ethical standards on innovative pharmaceutical companies.
In response to a recent criticism “It is irrational to provide preferential ...
Template for financial gain & expenditure report still causes more questions in pharma industry
While getting ready for the ‘obligation of the financial gain & expenditure report’ that will be enforced from the next year, the pharmaceutical industry has raised more questions about methods of completing the repor...
Hanmi Pharm acquires approval of hypertension/hyperlipidemia treatmentHanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) announced on the 17th that ‘Amosartan Q,’ a 3-substance combination drug with 2 antihypertensive substances and 1 anti-hyperlipidem...
|
Would it be possible for small pharmas to conduct co-R&D?
Chairman Yong-Joon Jo(CEO/President of Dongkoo Bio&Pharma) at the Korea Pharmaceutical Ind. Coop., which currently has approximately 100 medium and small pharmaceutical companies as its member, said at an interview wi...
What are the chances to legislate ‘prescription of creams for volume less than minimum packaging unit’
It seems regulations for ‘prescribing cream and ointment products for the volume less than the minimum packaging unit’ – it has been a problem in the pharmacy circles – would not be legislated.
Prescription of drugs ...
